Questcor Pharmacueticals, Inc. (QCOR) Tops Q4 EPS by 5c

Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $72.77 million.

For earnings history and earnings-related data on Questcor Pharmacueticals, Inc. (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• IMF chief says global economy weathered Iran war shock well
• nCino, Inc. (NCNO) Reports Q2 EPS of $0.05, Offers Guidance